Given unclear roles of COX1 in AD19–21 and known capillary constrictions in pathology broadly22–26, our findings raise the intriguing possibility for microglial COX1 as a promising therapeutic target in modulating the vascular deficits in AD specifically and brain pathology more broadly. This evidence concerns the gene PTGS1 and Alzheimer disease.